HHS Steps Up HIPAA Enforcement in 2016, Launching Phase 2 of the HIPAA Audit Program and Announcing Additional Enforcement Actions

Mar 24, 2016

Reading Time : 5 min

Phase 2 HIPAA Audits Have Begun

The HITECH Act requires OCR to perform periodic audits of both covered entities and their business associates for compliance with the Privacy, Security, and Breach Notification Rules adopted under HIPAA and the HITECH Act.

Phase 1 of the HIPAA Audit Program was conducted as a pilot program in 2011 and 2012, and focused on HIPAA covered entities (e.g., health plans, hospitals and other health care providers that are directly subject to HIPAA). OCR assessed 115 entities and conducted a comprehensive evaluation of the effectiveness of the pilot program before implementing Phase 2.

Notably, Phase 2 audits will target business associates in addition to covered entities. Business associates include the many vendors, service providers and other entities that create, receive, maintain or transmit health information in the course of providing services for hospitals, health plans and other covered entities.

In announcing the launch, OCR Director Jocelyn Samuels indicated that Phase 2 will involve more than 200 desk and on-site audits of covered entities and business associates. According to OCR’s website, Phase 2 will be broken into three rounds of audits: round one will involve desk audits of covered entities, round two will involve desk audits of business associates, and round three will involve on-site audits of both covered entities and business associates. OCR expects the desk audits to be completed by the end of December 2016. The on-site audits are expected to examine a broader scope of requirements than the desk audits.

The Phase 2 audit process is already under way. OCR has begun sending entities emails seeking to confirm contact information. The agency intends to identify covered entities and business associates of various types and determine which may be appropriate to include in pools of potential auditees. Once entity contact information is obtained, a pre-audit screening questionnaire will be issued. Entities selected for audits will be notified by email and will be required to submit requested documents through a portal on the OCR website.

OCR is developing audit protocols for Phase 2, which will be posted on OCR’s website once they are available. The audits are expected to focus on compliance with requirements relating to risk analyses and risk management, notices of privacy practices, affording patients access to their medical records and breach notification, among other issues.

There are several steps that covered entities and business associates should take now to prepare for the Phase 2 audit process, including:

  • Review information available about the Phase 2 audits. The OCR website contains information on Phase 2, along with a list of frequently asked questions. You should review this information and determine how audit-related requests would be handled within your organization.
  • Compile a list of business associates, complete with current contact information and business associate agreements. During the pre-audit screening process, OCR will ask for an inventory of business associates.
  • Prepare to gather all HIPAA privacy, security and breach notification policies and procedures and other compliance documentation. You should confirm that you know the location of all core HIPAA compliance documentation. OCR expects audited entities to submit electronic versions of requested information within 10 business days of the date on the information request. In particular, you should ensure that a HIPAA-compliant risk assessment has been performed and that relevant documentation is readily available. You should address any gaps in documentation that may be discovered in the process.
  • Conduct a practice audit based on the Phase 1 protocol. OCR has not yet released the Phase 2 audit protocol, but the Phase 1 audit protocol is still available online.
  • Adjust settings on spam and junk mail folders to ensure that any audit-related communications are received. Entities subject to HIPAA should be on the lookout for emails from OCR. Audit-related emails will be sent from OSOCRAudit@hhs.gov and OCR expects entities to check spam and junk mail folders for correspondence.

Recent HIPAA Penalties and Settlements Send a Signal

Covered entities and business associates can also learn valuable lessons from OCR’s recent enforcement actions. 2016 has already seen three major announcements in OCR enforcement actions. This activity signals the seriousness with which regulators continue to approach HIPAA compliance.

Most recently, OCR announced on March 17, 2016, that the Feinstein Institute for Medical Research agreed to pay $3.9 million to settle charges that it violated the HIPAA Privacy and Security Rules by failing to address potential risks to the confidentiality and integrity of electronic protected health information (ePHI). OCR initiated its investigation after Feinstein filed a breach report indicating that a laptop computer containing ePHI of approximately 13,000 patients and research participants was stolen from an employee’s car in September 2012.

Just one day earlier, on March 16, 2016, OCR announced that North Memorial Health Care of Minnesota, a comprehensive, not-for-profit health care system, agreed to pay $1.55 million to settle charges that it violated the HIPAA Privacy and Security Rules by neglecting to execute a business associate agreement and failing to complete a HIPAA-compliant risk assessment. OCR launched its investigation of North Memorial after receiving a breach report in September 2011 indicating that an unencrypted laptop was stolen from the locked vehicle of a business associate’s workforce member, impacting the protected health information of 9,497 individuals.

In addition, an HHS Administrative Law Judge ruled on February 3, 2016, that Lincare, Inc., a provider of respiratory care, infusion therapy and medical equipment to in-home patients, violated HIPAA and required Lincare to pay $239,800 in civil money penalties (CMPs) imposed by OCR. This was only the second time in history that OCR sought CMPs for HIPAA violations. OCR investigated a complaint that a Lincare employee had moved, leaving behind documents containing protected health information of 278 patients. The investigation revealed that Lincare had insufficient policies and procedures, including an unwritten policy requiring certain employees to store protected health information in their own cars. OCR indicated that although Lincare was aware of the investigation and the deficiencies found, the company took only limited action to improve compliance.

Conclusion

OCR remains committed to HIPAA enforcement activities. Covered entities and business associates should heed the warning and act now to shore up compliance. Through audit preparedness activities, entities may achieve a higher level of compliance and reduce risks, giving the efforts value beyond improving readiness to respond to audit requests that may come. OCR has been abundantly clear: negative audit findings can lead to an investigation.

Share This Insight

Previous Entries

Deal Diary

June 27, 2024

On June 24, 2024, the U.S. Securities and Exchange Commission (SEC) published five new Form 8-K Compliance and Disclosure Interpretations (C&DIs) expanding the agency’s interpretations of cybersecurity incident disclosures pursuant to Item 1.05 of Form 8-K. In July 2023, the SEC adopted final rules with respect to cybersecurity incidents that generally require public companies to disclose (i) material cybersecurity incidents within four business days after determining the incident was material and (ii) material information regarding their cybersecurity risk management, strategy and governance on an annual basis. We wrote about the final cybersecurity disclosure rules here.

...

Read More

Deal Diary

February 12, 2024

The Securities and Exchange Commission (SEC) recently adopted final rules (available here; also see the fact sheet and press release) representing significant changes to  special purpose acquisition companies (SPACs), shell companies and the disclosure of projections. These rules aim to enhance disclosures, protect investors and align the regulatory framework for SPACs with traditional IPOs. The following summarizes the key aspects of these rules.

...

Read More

Deal Diary

October 4, 2023

On September 20, 2023, the U.S. Securities and Exchange Commission (SEC) issued a final rule amending the so-called “Names Rule” (found here) that is “designed to modernize and enhance” protections under Rule 35d-1 of the Investment Company Act of 1940. The final rule is part of the SEC’s holistic efforts to regulate environmental, social and governance (ESG) matters, and is the SEC’s latest attempt to curb greenwashing in U.S. capital markets. The amendments require registered investment funds that include ESG factors in their names to place 80% of their assets in investments corresponding to those factors, thereby extending to ESG funds the SEC’s long-standing approach of regulating the names of registered funds to ensure they are marketed to investors truthfully. Fund complexes with more than $1 billion in assets will have two years from the final rule’s effective date (60 days after publication in the Federal Register) to comply, while fund complexes with less than $1 billion in assets will be given a compliance period of 30 months.

Chair Gary Gensler said “[t]he Names Rule reflects a basic idea: A fund’s investment portfolio should match a fund’s advertised investment focus. In essence, if a fund’s name suggests an investment focus, the fund in turn needs to invest shareholders’ dollars in a manner consistent with that investment focus. Otherwise, a fund’s portfolio might be inconsistent with what fund investors desired when selecting a fund based upon its name.” The sole dissenting vote against the rule modification, Commissioner Mark Uyeda, said “[w]ith these amendments, the Commission overemphasizes the importance of a fund’s name, as if to suggest that investors and their financial professionals need not look at the prospectus disclosures.” Commissioner Uyeda also expressed concern that fund investors will bear the increased compliance costs associated with the rule change.

...

Read More

Deal Diary

May 31, 2023

As discussed in our prior publication (found here), the Securities and Exchange Commission (SEC) adopted amendments on December 14, 2022, regarding Rule 10b5-1 insider trading plans and related disclosures. On May 25, 2023, the SEC issued three new compliance and disclosure interpretations (C&DIs) relating to the Rule 10b5-1 amendments.

...

Read More

Deal Diary

May 24, 2023

On May 15, 2023, the Eastern District of California ruled that California Assembly Bill No. 979 (“AB 979”) violates the Equal Protection Clause of the U.S. Constitution’s Fourteenth Amendment and 42 U.S.C. § 1981. As enacted, California’s Board Diversity Statute, required public companies with headquarters in the state to include a minimum number of directors from “underrepresented communities” or be subject to fines for violating the statute. AB 979 defines a “director from an underrepresented community” as “an individual who self-identifies as Black, African American, Hispanic, Latino, Asian, Pacific Islander, Native American, Native Hawaiian, or Alaska Native, or who self-identifies as gay, lesbian, bisexual, or transgender.”

...

Read More

Deal Diary

May 9, 2023

Update: On October 31, 2023, the Fifth Circuit granted the US Chamber of Commerce's petition for review of the SEC's share repurchase disclosure rules, holding that the SEC acted arbitrarily and capriciously in violation of the Administrative Procedure Act. The court directed the SEC to correct the defects within 30 days of the opinion. On December 1, 2023, the SEC informed the Fifth Circuit that it was unable to correct the rule's defects within 30 days of the opinion. On December 19, 2023, the Fifth Circuit vacated the SEC’s share repurchase disclosure rules.

...

Read More

Deal Diary

April 12, 2023

We have released our 2023 ESG Survey which includes a collection of reports reflecting on significant ESG themes and trends from 2022, as well as what we believe to be key developments for 2023.

...

Read More

Deal Diary

February 6, 2023

As companies begin preparing for the 2023 proxy season, we note that Institutional Shareholder Services Inc. (ISS) and Glass Lewis, the leading providers of corporate governance solutions and proxy advisory services, issued updated benchmark policies (proxy voting guidelines), which can be found here and here, respectively. The updated proxy voting guidelines generally focus on board accountability and oversight considerations and address topics such as climate accountability, board diversity, shareholder rights, corporate governance standards, executive compensation and social issues. What follows is a summary of the proxy voting guidelines published by ISS and Glass Lewis for the 2023 proxy season.

...

Read More

© 2024 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.